Cellromax Science Co., Ltd. (KOSDAQ:471820)
South Korea · Delayed Price · Currency is KRW 5,020.00
+165.00 (3.40%)
At close: May 14, 2026
Cellromax Science Revenue
In the year 2025, Cellromax Science had annual revenue of 22.18B KRW with 2.56% growth. Cellromax Science had revenue of 4.48B in the quarter ending December 31, 2025, a decrease of -18.54%.
Revenue
22.18B
Revenue Growth
+2.56%
P/S Ratio
2.50
Revenue / Employee
633.83M
Employees
35
Market Cap
55.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.18B | 553.61M | 2.56% |
| Dec 31, 2024 | 21.63B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition